CA Patent

CA2696977C — Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof

Assigned to Pharmathen SA · Expires 2012-12-04 · 13y expired

What this patent protects

The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a pyrrolidone anticonvulsant agent, and in particular Levetiracetam or a pharmaceutical acceptable salt or derivative thereof, in combination with …

USPTO Abstract

The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a pyrrolidone anticonvulsant agent, and in particular Levetiracetam or a pharmaceutical acceptable salt or derivative thereof, in combination with an effective diluent, such as Dibasic Calcium Phosphate, and additional pharmaceutical excipients, and a process for the preparation thereof by wet granulation.

Drugs covered by this patent

Patent Metadata

Patent number
CA2696977C
Jurisdiction
CA
Classification
—
Expires
2012-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Pharmathen SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.